A memory B cell response to Zika virus in dengue-infected patients produced antibodies that were poorly neutralizing in vitro and instead enhanced infection.
An oral mix of a pre- and probiotic can decrease deaths from the condition, according to the results of a large clinical trial conducted in rural India.
There is little evidence that full treatment durations discourage the development of drug-resistant bacteria.
Researchers continue to identify new T-cell subtypes—and devise ways to use them to fight cancer. The Scientist attempts to catalog them all.
The paper describing the gene-editing method is retracted.
An arrest warrant has been issued for Wyndham Lathem of Northwestern University in connection with a stabbing death in Chicago.
Another case of HIV remission emerges, this time in a South African girl diagnosed as an infant and disease-free for more than eight years.
A new study adds to the evidence that mammalian cells can use small interfering RNAs to defend against viruses, but questions remain about physiological importance.
In tissue samples from rhesus macaques, researchers find the virus in the same immune-privileged sites where Ebola has been found to persist in humans.
Phage therapy is but one example of using biological entities to reduce our reliance on antibiotics and other failing chemical solutions.
The prominent researcher has been put on administrative leave pending an investigation into unspecified allegations.
The 20-year project calls into question the conventional wisdom about the role plants will play in mitigating future climate change.
The US Senate narrowly approved the politician, who does not have a science background.
Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
© 1986-2018 The Scientist
